Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Kalkine
kalkine.com.au > news > energy > 7-asx-energy-stocks-to-watch-in-2026-santos-viva-energy-strike-energy-and-more

7 ASX Energy Stocks to Watch in 2026: Santos, Viva Energy, Strike Energy and More

3+ hour, 58+ min ago   (543+ words) Amplitude Energy Limited (ASX: AEL) Amplitude Energy, formerly Cooper Energy, remains focused on supplying natural gas to Australia's East Coast market. The company operates offshore assets in the Otway and Gippsland Basins while maintaining exposure to oil production in the…...

Kalkine
kalkine.com.au > news > announcements > australiansuper-reduces-skycity-entertainment-stake-below-5-threshold-following-series-of-share-sales

AustralianSuper Reduces SkyCity Entertainment Stake Below 5% Threshold Following Series of Share Sales

7+ hour, 48+ min ago   (88+ words) AustralianSuper Pty Ltd has ceased to hold a substantial shareholding in SkyCity Entertainment Group Ltd (SKC.NZ), reducing its stake from 6.95% to 4.85% through a series of share sales executed between 3 and 17 July 2026. The reduction means the major Australian superannuation fund…...

Kalkine
kalkine.com.au > news > announcements > siteminder-director-samantha-lawson-steps-down-final-interest-notice-filed

SiteMinder Director Samantha Lawson Steps Down, Final Interest Notice Filed

13+ hour, 21+ min ago   (994+ words) Kalkine...

Kalkine
kalkine.com.au > news > announcements > alterity-therapeutics-ceo-to-present-at-virtual-btig-biotechnology-conference-2026

Alterity Therapeutics CEO to Present at Virtual BTIG Biotechnology Conference 2026

7+ hour, 38+ min ago   (1153+ words) Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE), a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative diseases, announced that Chief Executive Officer Dr. David Stamler will participate in the virtual BTIG Biotechnology Conference 2026 on 28–29 July 2026. The company will conduct one-on-one…...

Kalkine
kalkine.com.au > news > announcements > citibank-launches-extended-leverage-investment-products-across-asx-blue-chip-stocks-with-855-interest-rate

Citibank Launches Extended Leverage Investment Products Across ASX Blue-Chip Stocks with 8.55% Interest Rate

8+ hour, 13+ min ago   (1218+ words) Citibank has introduced a suite of instalment MINIs (Margin Instalment Notes) across major Australian-listed companies, effective from 22 July 2026. The products, branded as CitiFirst Instalment MINIs, offer leveraged exposure to established ASX constituents including BHP Group, ANZ, ASX Limited, and others,…...

Kalkine
kalkine.com.au > news > announcements > ceretas-limited-officially-listed-on-asx-with-8-million-capital-raise-for-alzheimers-ultrasound-technology

Ceretas Limited Officially Listed on ASX With $8 Million Capital Raise for Alzheimer's Ultrasound Technology

7+ hour, 56+ min ago   (1110+ words) Ceretas Limited (ASX: CTS), a medical technology company developing a portable, non-invasive therapeutic ultrasound platform for treating Alzheimer's disease and other neurodegenerative conditions, was admitted to the Official List of ASX on Tuesday, 21 July 2026. The company commenced quotation on Thursday,…...

Kalkine
kalkine.com.au > news > announcements > ceretas-limited-advances-alzheimers-ultrasound-platform-with-239-million-government-grant

Ceretas Limited Advances Alzheimer's Ultrasound Platform With $2.39 Million Government Grant

7+ hour, 42+ min ago   (1213+ words) Ceretas Limited (ASX: CTS), a Brisbane-based therapeutic ultrasound developer, has reported interim financial results demonstrating substantial progress in its research and development activities during the half-year ended 31 December 2025. The company received $2.39 million in government funding from the Australian Government's MRFF…...

Kalkine
kalkine.com.au > news > announcements > conneqt-health-achieves-record-13m-consumer-revenue-as-cloud-platform-advances-fda-review

CONNEQT Health Achieves Record $1.3m Consumer Revenue as Cloud Platform Advances FDA Review

8+ hour, 28+ min ago   (1105+ words) CONNEQT Health Limited (ASX: CQT), a digital health technology company, has reported record quarterly consumer revenue of $1.3 million for the June quarter 2026, representing 21% quarter-on-quarter growth. The company also achieved a significant strategic milestone by lodging an FDA Pre-Submission package for…...